Скачать
Will DESTINY-Breast09 Change the Standard of Care for HER2+ mBC?
Автор: Urban Health Today
Загружено: 2025-07-29
Просмотров: 71
Описание:
Sadie Dobrozsi, MD, MS, medical director of Genetic Testing and Oncology Imaging for Evolent, discusses new data presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting from the DESTINY-Breast 09 trial, which focused on front-line treatment for human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer. The trial found improved progression-free survival (PFS) in this hard-to-treat subtype using the combination of trastuzumab deruxtecan (T-DXd) plus pertuzumab. Dr. Dobrozsi discusses how these new data might redefine the current standard of care, treatment accessibility, and key limitations of this study.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
![Oncology Grand Rounds: HER2+ Breast Cancer: 40 Years of Progress - May 6, 2024 [#Repost 2025]](https://ricktube.ru/thumbnail/GyKZ3zcC4mc/mqdefault.jpg)
